Not Yet RecruitingNot Applicable

Permian Health Women's Lung Health Study

The Gambia350 participantsStarted 2023-12

Plain-language summary

The goal of this cross-sectional observational study is to estimate the prevalence of lung function impairment as measured by spirometry in a population of Gambian women aged 15 and older. The main question\[s\] it aims to answer are: * What is the prevalence of lung function impairment in Gambian women * What is the prevalence of eosinophilic inflammation in Gambian women Consenting participants will undergo * Spirometry * Fractional exhaled nitric oxide (FENO) testing * α1-antitrypsin testing in patients with lung function impairment as assessed by spirometry

Who can participate

Age range15 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * Self-identified female sex * Age \> 15 years: This age cutoff was chosen (as opposed to 18) because of the unique cultural norms and practices in the country where experiences and exposures occur at an earlier age than women in Western countries. Exclusion criteria: * Age \< 15 years * Non-resident household member * Any acutely unwell individual * Pregnancy * Any known history of active pulmonary disease (including TB) on treatment. * Individuals unable or unwilling to give consent.

What they're measuring

Prevalence of lung function Impairment as measured by spirometry

Timeframe: Through study completion, an average of 1 year

Trial details

NCT IDNCT06029543

SponsorPermian Health Lung Institute

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-12

View on ClinicalTrials.gov More COPD trials